Technology
Health
Medical

Nuvectra

$3.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (1.02%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Nuvectra and other stocks, options, ETFs, and crypto commission-free!

About

Nuvectra Corporation Common Stock, also called Nuvectra, is a neurostimulation medical device company, which engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra segment. Read More The Nuvectra segment is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The company was founded on November 14, 2008 and is headquartered in Plano, TX.

Employees
200
Headquarters
Plano, Texas
Founded
2008
Market Cap
69.92M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
233.11K
High Today
$4.21
Low Today
$3.91
Open Price
$4.00
Volume
383.75K
52 Week High
$25.17
52 Week Low
$3.85

Collections

Technology
Health
Medical
2016 IPO
US
North America

News

Simply Wall StMay 8

Have Insiders Been Buying Nuvectra Corporation (NASDAQ:NVTR) Shares?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So we’ll take a look at whether insiders have been buying or selling shares in Nuvectra Corporation (NASDAQ:NVTR). What Is Insider Selling? It’s quite normal to see compan...

77
Seeking AlphaMay 4

Nuvectra Corporation (NVTR) CEO Fred Parks on Q1 2019 Results - Earnings Call Transcript

Nuvectra Corporation (NASDAQ:NVTR) Q1 2019 Earnings Conference Call May 1, 2019 4:30 PM ET Company Participants Tram Bui - The Ruth Group, Investor Relations Fred Parks - Chief Executive Officer Walter Berger - Chief Operating Officer and Chief Financial Officer Paul Hanchin - President Conference Call Participants Dave Turkaly - JMP Securities Matt Wizman - Raymond James Bruce Nudell - SunTrust Robinson Humphrey Operator Good day, ladies and gentlemen, and welcome to the Q1 2019 Nuvectra earning...

42
Seeking AlphaMay 2

Q1 miss and longer Virtis timeline pressure Nuvectra, down 31%

Thinly traded micro cap Nuvectra (NVTR -30.5% ) is down on over four times normal volume following the release of Q1 results that fell shy of consensus.

48

Earnings

-$1.16
-$0.99
-$0.82
-$0.65
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.